Thomas P. Gibbons
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Invesco to Report Q3 2026 Results; Dividends Declared. Invesco has announced it will release its third-quarter 2026 financial results soon. The company also declared dividends for its closed-end funds, a move that may appeal to income-focused investors given the stock's 5.79% dividend yield. Recent news coverage has focused on the firm's various ETFs and mutual funds, highlighting its broad product lineup.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BNY Q3 Earnings Show Margin Gains and Raised Outlook. Bank of New York Mellon reported third-quarter results that highlighted margin improvements and a raised outlook, with a focus on AI initiatives. While the market reaction was muted, analysts noted the earnings beat. One firm maintained its stance but lowered its price target to $165, reflecting a cautious view despite the positive fundamentals.
Transaction History
| ALLY | ▲ Buy | Grant | 1,034 | $48K | 7/9/2026 | View on chart |
| ALLY | ▲ Buy | Grant | 3,632 | $153K | 5/15/2026 | View on chart |
| IVZ | ▲ Buy | Grant | 8,112 | $0 | 5/15/2026 | View on chart |
| ALLY | ▲ Buy | Grant | 1,211 | $48K | 4/9/2026 | View on chart |
| ALLY | ▲ Buy | Grant | 1,049 | $48K | 1/9/2026 | View on chart |
| ALLY | ▲ Buy | Grant | 1,212 | $0 | 10/8/2025 | View on chart |
| ALLY | ▲ Buy | Grant | 1,072 | $0 | 7/14/2025 | View on chart |
| ALLY | ▲ Buy | Grant | 4,266 | $153K | 5/15/2025 | View on chart |
| IVZ | ▲ Buy | Grant | 12,728 | $0 | 5/15/2025 | View on chart |
| ALLY | ▲ Buy | Grant | 892 | $0 | 4/15/2025 | View on chart |
| ALLY | ▲ Buy | Grant | 903 | $0 | 1/10/2025 | View on chart |
| ALLY | ▲ Buy | Grant | 914 | $0 | 10/3/2024 | View on chart |
| ALLY | ▲ Buy | Grant | 820 | $0 | 7/5/2024 | View on chart |
| ALLY | ▲ Buy | Grant | 3,528 | $145K | 5/15/2024 | View on chart |
| IVZ | ▲ Buy | Grant | 11,955 | $0 | 5/15/2024 | View on chart |
| ALLY | ▲ Buy | Grant | 801 | $0 | 4/4/2024 | View on chart |
| ALLY | ▲ Buy | Grant | 4,728 | $0 | 8/1/2023 | View on chart |
| IVZ | ▲ Buy | Grant | 14,007 | $0 | 5/15/2023 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 15,363 | $650K | 10/31/2022 | View on chart |
| BNY | ▼ Sell | Open Market | 105,062 | $4.5M | 8/8/2022 | View on chart |
| BNY | ▼ Sell | Open Market | 67,000 | $2.9M | 8/8/2022 | View on chart |
| BNY | ▼ Sell | Open Market | 67,000 | $2.9M | 8/8/2022 | View on chart |
| BNY | ▲ Buy | Grant | 41,041 | $0 | 2/18/2022 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 6,466 | $403K | 2/11/2022 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 5,534 | $351K | 2/10/2022 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 10,023 | $638K | 2/8/2022 | View on chart |
| BNY | ▲ Buy | Grant | 58,535 | $0 | 2/7/2022 | View on chart |
| BNY | ▼ Sell | Gift | 67,000 | $0 | 1/26/2022 | View on chart |
| BNY | ▼ Sell | Gift | 67,000 | $0 | 1/26/2022 | View on chart |
| BNY | ▼ Sell | Gift | 67,000 | $0 | 1/26/2022 | View on chart |
| BNY | ▼ Sell | Gift | 67,000 | $0 | 1/26/2022 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 15,919 | $946K | 10/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Wells Fargo Downgrades Ally Financial to Equal-Weight
Wells Fargo downgraded Ally Financial to Equal-Weight and lowered its price target to $42. This action stands out against a broader analyst consensus that currently averages a $51.95 target. The stock is trading near its 52-week low, reflecting recent market pressure despite a valuation that some analysts view as undervalued.
Wells Fargo Downgrades Ally Financial to Equal-Weight. Wells Fargo downgraded Ally Financial to Equal-Weight and lowered its price target to $42. This action stands out against a broader analyst consensus that currently averages a $51.95 target. The stock is trading near its 52-week low, reflecting recent market pressure despite a valuation that some analysts view as undervalued.